53
Participants
Start Date
April 13, 2022
Primary Completion Date
January 1, 2027
Study Completion Date
January 1, 2029
Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF
"Epicardial linear lesions will be created endoscopically using the EPi-Sense®-Guided Coagulation System or EPi-Sense ST™ Coagulation System throughout the posterior left atrium and along the pericardial reflections from a trans-diaphragmatic or sub-xyphoid access without any chest incisions. Posterior and other linear lesions such as a roof lesion and mitral valve isthmus lesion will not be created during the endocardial component of the convergent procedure. This will be done endocardially using an irrigated endocardial ablation catheter.~Once the study lesion pattern has been created by coagulating cardiac tissue using the EPi-Sense®-Guided Coagulation System or EPi-Sense ST™ Coagulation System and the endocardial ablation catheter, the pulmonary veins must be evaluated for entrance and/or exit block to confirm isolation. ."
MedStar Union Memorial Hospital, Baltimore
Wellstar Health System, Marietta
Emory Saint Joseph Hopsital, Atlanta
Orlando Health, Orlando
Baycare Health Systems, Clearwater
Avera Heart Hospital of SD, Sioux Falls
University of Utah, Salt Lake City
Sutter Bay Hospitals, San Francisco
Hartford Hospital, Hartford
Southcoast Hospitals Group, New Bedford
AtlantiCare Medical Center, Atlantic City
St Thomas, London
Lead Sponsor
AtriCure, Inc.
INDUSTRY